探索利用遗传学对大麻使用障碍的药物重新定位和精准医学的机会
Laura A Greco1,2, William R Reay1,2, Christopher V Dayas1
1School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, Australia.
Addiction biology
|July 27, 2023
概括
大麻使用障碍 (CUD) 缺乏药理疗法. 基因分析确定了PDE4B作为潜在的药物重定向目标,显示了与炎症和其他物质使用障碍的联系.
科学领域:
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 大麻使用障碍 (CUD) 是一个广泛的公共卫生问题,目前没有药理疗法.
- 目前对CUD分子基础的研究尚未产生有效的治疗策略.
- 基因分析为确定CUD的药物重用机会提供了一个有希望的途径.
研究的目的:
- 通过遗传分析识别与CUD相关的可药物基因.
- 将转录基因和蛋白质基因数据与遗传发现相结合.
- 探索CUD和可操作的生化特征之间的遗传相关性.
主要方法:
- 全基因组关联研究 (GWAS) 数据聚合以优先考虑基因.
- 概率精细映射以确定可信的因果变异.
- 将基因/蛋白质表达数据与GWAS结果的整合.
- 用生物化学和免疫标记物进行遗传相关性分析.
主要成果:
- 二酶基因PDE4B被优先考虑为CUD的潜在药物重定向标.
- 因果性PDE4B变异与炎症和其他物质使用表型相关.
- 在全血中发现了一种新的CUD相关基因NPTX1.
- 在CUD和免疫标记物 (例如淋巴细胞计数) 和血清甘油三之间观察到遗传重叠.
结论:
- 基因分析强调PDE4B是CUD药物重定向的关键目标.
- 新的遗传关联,包括NPTX1和氨基酶,涉及到CUD中的新生物学途径.
- CUD与免疫系统功能和代谢特征有共同的遗传联系,表明潜在的治疗点.
相关概念视频
Human Genetics
614
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
614
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Behavioral Genetics and Its Designs
411
Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
411
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
236
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
236
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
319
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
319


